Trident Texofab Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

99.48

96.36

84.29

49.93

90.96

Operating profit

5.61

6.31

4.79

2.88

4.56

Interest

4.04

3.71

2.83

2.85

2.41

Gross profit

2.84

4.50

2.70

1.88

2.45

EPS (Rs)

1.07

2.20

0.98

0.35

2.15

Other income

1.26

1.90

0.74

1.85

0.31

Stock adjustment

-2.56

-3.94

0.95

2.68

-6.09

Raw material

19.63

23.58

14.31

5.29

8.44

Power and fuel

-

-

-

-

-

Employee expenses

2.69

2.77

2.40

1.96

2.46

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

74.11

67.64

61.85

37.12

81.59

Provisions made

-

-

-

-

-

Depreciation

1.65

1.64

1.47

1.02

0.80

Taxation

0.09

0.51

0.29

0.55

0.49

Net profit / loss

1.08

2.22

0.98

0.35

0.86

Extra ordinary item

-0.02

-0.13

0.04

0.05

-0.30

Prior year adjustments

-

-

-

-

-

Equity capital

10.07

10.07

10.07

10.07

4.00

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

5.64

6.55

5.68

5.77

5.01

GPM (%)

2.82

4.58

3.17

3.63

2.69

NPM (%)

1.07

2.26

1.16

0.68

0.94